These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 24949260)
1. Assessment of packed bed bioreactor systems in the production of viral vaccines. Rajendran R; Lingala R; Vuppu SK; Bandi BO; Manickam E; Macherla SR; Dubois S; Havelange N; Maithal K AMB Express; 2014; 4():25. PubMed ID: 24949260 [TBL] [Abstract][Full Text] [Related]
2. Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector Production. Leinonen HM; Lepola S; Lipponen EM; Heikura T; Koponen T; Parker N; Ylä-Herttuala S; Lesch HP Hum Gene Ther; 2020 Mar; 31(5-6):376-384. PubMed ID: 32075423 [TBL] [Abstract][Full Text] [Related]
3. Process Development of Adenoviral Vector Production in Fixed Bed Bioreactor: From Bench to Commercial Scale. Lesch HP; Heikkilä KM; Lipponen EM; Valonen P; Müller A; Räsänen E; Tuunanen T; Hassinen MM; Parker N; Karhinen M; Shaw R; Ylä-Herttuala S Hum Gene Ther; 2015 Aug; 26(8):560-71. PubMed ID: 26176404 [TBL] [Abstract][Full Text] [Related]
4. Pseudorabies virus production using a serum-free medium in fixed-bed bioreactors with low cell inoculum density. Nie J; Sun Y; Peng F; Han F; Yang Y; Liu X; Liu C; Li Y; Bai Z Biotechnol Lett; 2020 Dec; 42(12):2551-2560. PubMed ID: 32816175 [TBL] [Abstract][Full Text] [Related]
5. Development and Optimization of AAV hFIX Particles by Transient Transfection in an iCELLis(®) Fixed-Bed Bioreactor. Powers AD; Piras BA; Clark RK; Lockey TD; Meagher MM Hum Gene Ther Methods; 2016 Jun; 27(3):112-21. PubMed ID: 27229773 [TBL] [Abstract][Full Text] [Related]
6. Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor. Powers AD; Drury JE; Hoehamer CF; Lockey TD; Meagher MM Mol Ther Methods Clin Dev; 2020 Dec; 19():1-13. PubMed ID: 32995355 [TBL] [Abstract][Full Text] [Related]
7. Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor. Valkama AJ; Leinonen HM; Lipponen EM; Turkki V; Malinen J; Heikura T; Ylä-Herttuala S; Lesch HP Gene Ther; 2018 Jan; 25(1):39-46. PubMed ID: 29345252 [TBL] [Abstract][Full Text] [Related]
8. Production of Recombinant Rabies Virus Glycoprotein by Insect Cells in a Single-Use Fixed-Bed Bioreactor. Ventini-Monteiro DC; Astray RM; Pereira CA Methods Mol Biol; 2018; 1674():87-94. PubMed ID: 28921430 [TBL] [Abstract][Full Text] [Related]
9. Production Process Development of Pseudorabies Virus Vaccine by Using a Novel Scale-Down Model of a Fixed-Bed Bioreactor. Nie J; Sun Y; Peng F; Li X; Yang Y; Liu X; Li Y; Liu C; Bai Z J Pharm Sci; 2020 Feb; 109(2):959-965. PubMed ID: 31604085 [TBL] [Abstract][Full Text] [Related]
10. Insect cell entrapment, growth and recovering using a single-use fixed-bed bioreactor. Scaling up and recombinant protein production. Ventini-Monteiro D; Dubois S; Astray RM; Castillo J; Pereira CA J Biotechnol; 2015 Dec; 216():110-5. PubMed ID: 26481831 [TBL] [Abstract][Full Text] [Related]
11. Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor. Berrie DM; Waters RC; Montoya C; Chatel A; Vela EM Vaccine; 2020 Apr; 38(20):3639-3645. PubMed ID: 32247568 [TBL] [Abstract][Full Text] [Related]
12. Production of influenza H1N1 vaccine from MDCK cells using a novel disposable packed-bed bioreactor. Sun B; Yu X; Kong W; Sun S; Yang P; Zhu C; Zhang H; Wu Y; Chen Y; Shi Y; Zhang X; Jiang C Appl Microbiol Biotechnol; 2013 Feb; 97(3):1063-70. PubMed ID: 22945265 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Single-Use Fixed-Bed Bioreactors in Scalable Virus Production. Lesch HP; Valonen P; Karhinen M Biotechnol J; 2021 Jan; 16(1):e2000020. PubMed ID: 32971565 [TBL] [Abstract][Full Text] [Related]
14. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media. Rourou S; Ben Zakkour M; Kallel H Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor. Offersgaard A; Duarte Hernandez CR; Pihl AF; Costa R; Venkatesan NP; Lin X; Van Pham L; Feng S; Fahnøe U; Scheel TKH; Ramirez S; Reichl U; Bukh J; Genzel Y; Gottwein JM Vaccines (Basel); 2021 Jun; 9(7):. PubMed ID: 34209694 [TBL] [Abstract][Full Text] [Related]
16. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Rourou S; van der Ark A; van der Velden T; Kallel H Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281 [TBL] [Abstract][Full Text] [Related]
17. Optimizing and developing a scalable, chemically defined, animal component-free lentiviral vector production process in a fixed-bed bioreactor. Fiol CR; Collignon ML; Welsh J; Rafiq QA Mol Ther Methods Clin Dev; 2023 Sep; 30():221-234. PubMed ID: 37528866 [TBL] [Abstract][Full Text] [Related]
18. Bioreactor production of rVSV-based vectors in Vero cell suspension cultures. Kiesslich S; Kim GN; Shen CF; Kang CY; Kamen AA Biotechnol Bioeng; 2021 Jul; 118(7):2649-2659. PubMed ID: 33837958 [TBL] [Abstract][Full Text] [Related]
19. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells. Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017 [TBL] [Abstract][Full Text] [Related]
20. Production of rhEPO with a serum-free medium in the packed bed bioreactor. Deng J; Yang Q; Cheng X; Li L; Zhou J Chin J Biotechnol; 1997; 13(4):247-52. PubMed ID: 9631260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]